R. N. Dalton

Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria?

B. Widmer, J. Edge, T. Jones, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)

D. Dunger, A. Neil, J. Deanfield, 2009, BMC pediatrics.

Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation

D. Dunger, J. Deanfield, M. Marcovecchio, 2019, European heart journal.

ACE Inhibitors and Statins in Adolescents with Type 1 Diabetes

D. Dunger, T. Jones, J. Deanfield, 2017, The New England journal of medicine.

Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes

D. Dunger, R. Moineddin, J. Scholey, 2016, Diabetes Care.

Reduced endogenous secretory receptor for advanced glycation end products (esRAGE) in young people with Type 1 diabetes developing microalbuminuria

D. Dunger, B. Widmer, M. Marcovecchio, 2009, Diabetic medicine : a journal of the British Diabetic Association.

Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: Consensus from an international workshop.

T. Derks, S. Pendyal, S. K. Uçar, 2024, Molecular genetics and metabolism.